The price increase yesterday to 0.43 CAD is exactly what the MedMira chart needs. Above 0.50 CAD we get a positive reversal signal that ends the downward column and at the same time initiates a new upward trend as we are above half the downward column. At 1.05 CAD we get a cyclical buy signal with a price target of 1.75 CAD which is the old resistance. The old high of CAD 2.50 from the year 2003 would then also be conceivable. Trade your opinion on Pfizer! , 94 Ask 0.26 About the product Click on the disclaimer document to obtain the base prospectus as well as the final terms and the key information sheets. Please also note the further information on this advertisement. I know this reads extremely promisingly and would be insane returns. But if I look at the markets and what's going on there, then I wouldn't be surprised with the technological and patented platform background that MedMira has. I see CAD 2.50 and more if there is a takeover. The interest of the big players in the industry should be aroused when the FDA approval for the new improved test comes. Incidentally, the process is also running with Health Canada and they are working on a production setup for 50,000 tests a day! MedMira number 1 in INN Biotech Investing News!